Mangoceuticals, Inc. (MGRX)

Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.48	0.06	0.74	0.68
Cash & Short-Term Investments	0.48	0.06	0.74	0.68
Cash Growth	551.15%	-92.06%	8.22%	-
Inventory	-	-	0.02	-
Other Current Assets	0.12	0.02	0.08	0.01
Total Current Assets	0.6	0.08	0.84	0.69
Net Property, Plant & Equipment	0.01	0.06	0.22	0.29
Other Intangible Assets	15.92	15.23	-	-
Other Long-Term Assets	-	-	-	0.02
Total Assets	16.53	15.37	1.05	1
Accounts Payable	0.53	0.84	0.14	0.03
Accrued Expenses	0	-	0.01	0
Short-Term Debt	0.1	0.15	-	0.17
Current Portion of Leases	0.01	0.06	0.06	0.06
Other Current Liabilities	0.16	0.37	-	-
Total Current Liabilities	0.8	1.43	0.21	0.26
Long-Term Leases	-	-	0.06	0.13
Total Long-Term Liabilities	-	-	0.06	0.13
Total Liabilities	0.8	1.43	0.28	0.39
Preferred Stock	0	0	-	-
Common Stock	0	0	0	0
Additional Paid-in Capital	53.61	33.64	12	2.63
Accumulated Other Comprehensive Income	-0	-0.01	-	-
Retained Earnings	-37.88	-20.08	-11.23	-2.02
Total Common Shareholders' Equity	15.73	13.55	0.77	0.61
Minority Interest	-0	-0	-	-
Shareholders' Equity	31.46	27.89	1.55	0.61
Total Liabilities & Equity	16.53	15.37	1.05	1
Total Debt	0.11	0.21	0.13	0.35
Net Cash (Debt)	0.37	-0.16	0.61	0.33
Net Cash Growth	-	-	84.95%	-
Net Cash Per Share	0.05	-0.08	0.57	0.46
Book Value	15.73	13.55	0.77	0.61
Book Value Per Share	2.19	6.84	0.72	0.85
Tangible Book Value	-0.19	-1.69	0.77	0.61
Tangible Book Value Per Share	-0.03	-0.85	0.72	0.85

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q